Insurers face long road high cost to cover obesity drugs after promising Wegovy heart health data CNBC

Insurers face long road high cost to cover obesity drugs after promising Wegovy heart health data  CNBC

A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023.  Novo Nordisk’s obesity drug Wegovy slashed the risk of… [+8431 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *